Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      A Study of Pemetrexed in Children With Recurrent Cancer
      Description

      To determine the response rate of pemetrexed given every 21 days for the treatment of children with relapsed or refractory osteosarcoma, Ewing's sarcoma/peripheral primitive neuroectodermal tumors (PNET), rhabdomyosarcoma, neuroblastoma, ependymoma, medulloblastoma/supratentorial PNET or non-brain stem high-grade glioma.

      Conditions
      OsteosarcomaMedulloblastomaSarcoma, Ewing'sNeuroblastoma (Measurable Disease)Neuroblastoma (MetaiodobenzylguanidinePositive Evaluable)RhabdomyosarcomaEpendymomaNon-brainstem High-grade Glioma
      Talk to us